AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Rhinach Plus Tablet

Prescription Icon
Prescription Required

Marketer

Abdach Healthcare Pvt. Ltd.

Salt Composition

Caffeine (30mg) + Chlorpheniramine Maleate (2mg) + Paracetamol (325mg) + Phenylephrine (10mg)

Overview Rhinach Plus Tablet

Combiflu Plus tablets offer symptomatic relief from the common cold. This medication temporarily alleviates nasal congestion and provides relief from allergy symptoms such as rhinorrhea and ocular irritation. Combiflu Plus should be taken as directed by your physician, with or without food; however, taking it with food may minimize potential stomach discomfort. Dosage is individualized based on your response and medical condition. Complete the prescribed course of treatment; premature discontinuation may lead to symptom recurrence and potential exacerbation. Inform your doctor of all other medications you are currently using, as interactions may occur. Commonly reported side effects include nausea, emesis, cephalalgia, agitation, and difficulty sleeping. These effects are usually transient and self-limiting. Report any concerning side effects to your doctor immediately. Drowsiness and vertigo are possible; avoid activities requiring alertness until the effects are known. Alcohol consumption should be avoided due to the potential for increased dizziness. Prior to commencing treatment, disclose any pre-existing hepatic or renal conditions, and inform your doctor if you are pregnant, planning a pregnancy, or breastfeeding to ensure appropriate dosage.

Uses of Rhinach Plus Tablet

Managing the common cold

Major Benefits of Rhinach Plus Tablet:

Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Rhinach Plus Tablets can be consumed with or without food, however, consistent timing is recommended.

Common Side effects of Rhinach Plus Tablet:

  • Headache
  • Tachycardia
  • Palpitations
  • Dizziness
  • Fear
  • Restlessness
  • Anxiety
  • Tremors
  • Insomnia (difficulty in sleeping)
  • Nausea
  • Weakness
  • Discomfort when urinating
  • Hallucination
  • Convulsion

How to use Rhinach Plus Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Rhinach Plus Tablets can be consumed with or without food; however, consistent timing is recommended.

How Rhinach Plus Tablet works:

Rhinach Plus Tablets combine caffeine, chlorpheniramine maleate, paracetamol, and phenylephrine to alleviate typical cold symptoms.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Rhinach Plus Tablet is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Rhinach Plus Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Breastfeeding mothers can likely use Rhinach Plus Tablet without significant harm to their infants. Available human data indicates minimal risk to the baby.

DrivingDrivingUNSAFE

Taking Rhinach Plus Tablets might reduce awareness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these effects are experienced.

KidneyKidneySAFE IF PRESCRIBED

The use of Rhinach Plus Tablets in individuals with kidney disease is likely safe. Existing evidence indicates dose modification may not be necessary, however, physician consultation is recommended. Patients with severe kidney impairment may experience increased drowsiness while taking Rhinach Plus Tablets.

LiverLiverCAUTION

Patients with liver impairment should use Rhinach Plus Tablet cautiously, potentially requiring a modified dosage. Physician consultation is advised.

What if you forget to take Rhinach Plus Tablet :

Should you forget to take a Rhinach Plus Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Rhinach Plus Tablet

LabelValue
Addictive None.
Treatment Category BREATHING

FAQs on Rhinach Plus Tablet

Rhinach Plus tablets contain caffeine, chlorpheniramine maleate, paracetamol, and phenylephrine hydrochloride. This formulation provides symptomatic relief from common cold symptoms such as muscle pain, headache, tiredness, fever, nasal congestion, watery eyes, sneezing, cough, and throat irritation.
Rhinach Plus Tablets include caffeine; therefore, it's advisable to abstain from other caffeine-containing medications or consumables. Coffee, tea, cola beverages, and chocolate should be omitted from your diet, as they could increase your overall caffeine consumption. Elevated caffeine levels may lead to insomnia, tremors, and/or chest pain. Furthermore, refrain from alcohol consumption (beer, wine, etc.) during treatment with this medication.
Keep medications in a cool, dry location, retaining them in their original packaging until use. Always store them where children cannot see or access them. Discard any leftover medication using appropriate methods to prevent accidental ingestion by children, pets, or others.
Adverse reactions to Rhinach Plus Tablet are infrequent and seldom reported. Promptly inform your physician should you experience allergic responses, skin eruptions or exfoliation, oral sores, respiratory difficulties, spontaneous bleeding, recurring fevers or infections, visual impairment, or rapid or erratic heartbeat.
Exceeding the prescribed dosage won't necessarily enhance efficacy; instead, it heightens the risk of adverse reactions and harmful effects. If your symptoms persist or worsen despite adhering to the recommended dosage, seek medical advice.
Rhinach Plus Tablets are contraindicated for individuals with hypertension, severe cardiac disease, cardiovascular disorders, a history of peptic ulcers, or hyperthyroidism. Physician consultation is required prior to use. Concurrent use with antidepressant medications, such as monoamine oxidase inhibitors (MAOIs) – including phenelzine and isocarboxazid – or tricyclic antidepressants (e.g., imipramine and amitriptyline), should be avoided.
Breastfeeding is not recommended during treatment with Rhinach Plus Tablets. The medication includes Chlorpheniramine, an antihistamine that can transfer to breast milk, potentially harming the infant. If prescribed Rhinach Plus, inform your physician of your breastfeeding status.
Rhinach Plus tablets contain caffeine, chlorpheniramine, paracetamol, and phenylephrine. This formulation provides symptomatic relief from cold symptoms such as muscle pain, headache, tiredness, elevated temperature, watery eyes, sneezing, cough, throat irritation, and nasal congestion.
Rhinach Plus Tablets include caffeine; therefore, it's advisable to forgo other caffeine-containing medications or foods. This includes coffee, tea, colas, and chocolate, as their consumption could elevate your overall caffeine level. Excessive caffeine may disrupt sleep, trigger tremors, and/or induce chest pain. Furthermore, refrain from alcohol (beer, wine, etc.) while using this medication.
Adverse reactions of a severe nature associated with Rhinach Plus Tablet are infrequent. Report to your physician immediately any occurrence of allergic responses, skin eruptions or exfoliation, oral ulcers, respiratory difficulties, spontaneous bleeding, recurring pyrexia or infections, visual impairment, or rapid or erratic heartbeat.
Increasing your medication dosage beyond the prescribed amount won't necessarily improve its effectiveness; instead, it heightens the risk of severe adverse reactions and potential poisoning. If your symptoms persist or worsen despite adhering to the recommended dosage, seek medical advice.
Rhinach Plus Tablet is contraindicated in patients with hypertension, severe cardiac disease, cardiovascular disorders, a history of peptic ulcers, or hyperthyroidism. Physician consultation is necessary before use. Concurrent use with antidepressant medications, such as monoamine oxidase inhibitors (MAOIs) – for example, phenelzine and isocarboxazid – or tricyclic antidepressants like imipramine and amitriptyline, should be avoided.
Breastfeeding is not recommended during Rhinach Plus Tablet use. The medication's antihistamine component, Chlorpheniramine, can transfer to breast milk, potentially harming the infant. If prescribed Rhinach Plus, notify your physician of your breastfeeding status.
Keep medications in a cool, dry location, retaining the original packaging until use. Maintain them out of children's reach and view. Discard leftover medications properly to prevent accidental ingestion by children, pets, or others.
Rhinach Plus Tablet combines caffeine, chlorpheniramine maleate, paracetamol, and phenylephrine hydrochloride to alleviate common cold symptoms. These symptoms can encompass muscle pain, headache, weariness, fever, lacrimation, sneezing, cough, pharyngitis, and nasal congestion.
Rhinach Plus Tablets include caffeine; therefore, it's advisable to limit additional caffeine consumption from other sources. This includes beverages such as coffee, tea, and cola, as well as chocolate. Combining caffeine sources may lead to sleep disturbances, tremors, and/or chest pain. Concurrent alcohol use (beer, wine, etc.) should also be avoided while using this medication.
Adverse reactions of significant severity associated with Rhinach Plus Tablet are infrequent. Promptly inform your physician should you experience allergic responses, skin eruptions or exfoliation, oral ulcers, respiratory difficulties, spontaneous bleeding, recurring fevers or infections, visual impairment, or a rapid or erratic pulse.
Exceeding the prescribed dosage won't necessarily enhance efficacy; instead, it heightens the risk of adverse reactions and potential poisoning. If your symptoms persist or worsen despite adhering to the recommended dosage, seek medical advice.
Rhinach Plus Tablet is contraindicated in patients with hypertension, severe cardiac disease, cardiovascular disorders, a history of peptic ulcers, or hyperthyroidism. Physician consultation is required before use. Concurrent use with antidepressant medications, specifically monoamine oxidase inhibitors (MAOIs) such as phenelzine and isocarboxazid, or tricyclic antidepressants like imipramine and amitriptyline, is inadvisable.
Breastfeeding is not recommended during Rhinach Plus Tablet use. The medication includes Chlorpheniramine, an antihistamine that can transfer to breast milk, potentially harming the infant. If prescribed Rhinach Plus, notify your physician of your breastfeeding status.
Keep medications in a cool, dry location, always in their original packaging until use. Securely store them where children cannot see or access them. Dispose of any leftover medication following the recommended guidelines to prevent accidental ingestion by children, pets, or others.
Rhinach Plus Tablet
31
MRP 38
18% off